{"id":5714,"date":"2021-10-12T15:10:20","date_gmt":"2021-10-12T14:10:20","guid":{"rendered":"https:\/\/www.cilcare.com\/?p=5714"},"modified":"2023-11-14T19:10:55","modified_gmt":"2023-11-14T18:10:55","slug":"aurore-marie-nominated-global-head-rd-operations-management","status":"publish","type":"post","link":"https:\/\/www.cilcare.com\/jp\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/","title":{"rendered":"Aurore Marie promoted as Global Head, R&D Operations Management, and CILcare\u2019s Board Member"},"content":{"rendered":"

Montpellier, October 13th, 2021<\/u><\/strong>: CILcare, the world leading CRO specialized in ear disorders, is pleased of nominating Aurore Marie at the position of Global Head, R&D Operations Management. In her new role, Aurore Marie will drive the support to production operations at global level and will serve as a new member of CILcare\u2019s Board. <\/strong><\/p>\n

For the past six years, Aurore Marie has served as R&D project Manager and Senior Operations Manager at CILcare, responsible for directing and executing Sponsor\u2019s studies and internal R&D programs, both in Montpellier France, and Lexington, MA USA. She was notably Principal Investigator on GLP ototoxicity and general toxicity studies over the 3 last years. Within her new position of Global Head, R&D Operations, she will manage and monitor CILcare\u2019s French and US-based operations and ensure maintaining highest level of excellence of the technology platform.<\/p>\n

\u201cWe are pleased to welcome Aurore in this new position and to the CILcare\u2019s board. Aurore is today an accomplished otology-scientist with a brilliant track-record of operations management. Her deep experience in managing preclinical studies in France and in the US with strong knowledge in the hearing field and electrophysiology measurements will be invaluable to CILcare and its customers.\u201d <\/em>comments Celia Belline, CEO.<\/p><\/blockquote>\n

Reporting directly to CILcare\u2019s CEO, Aurore will be working in close relationship with CILcare\u2019s US partner CBSET. In order to keep CILcare\u2019s at the forefront of innovation, she will be in charge of keeping and developing auditory technical and surgical skills needed to the next-generation medicines such as cell and gene therapies.<\/p>\n

\u201cI am delighted to be joining the CILcare\u2019s Board at this stage of the Company\u2019s development. CILcare\u2019s unique know-how allows to deliver high quality services to pharma, biotech, and medtech companies. I look forward to working with the Board to continue growing the Company and delivering value for our sponsors which will benefit to millions of hearing-impaired people worldwide.\u201d\u00a0<\/em>underlines Aurore Marie.<\/p><\/blockquote>\n

Aurore Marie holds a Master Degree in Project Management and Innovation in Biotechnology<\/em> and specialized in auditory in vivo<\/em> pharmacology.<\/p>\n

Contact:<\/p>\n

Marie PEYTAVY-IZARD, Marketing & Business Development Director<\/p>\n

+33 (0)7 69 74 19 05<\/p>","protected":false},"excerpt":{"rendered":"

Montpellier, October 13th, 2021: CILcare, the world leading CRO specialized in ear disorders, is pleased of nominating Aurore Marie at the position of Global Head, R&D Operations Management. In her new role, Aurore Marie will drive the support to production operations at global level and will serve as a new member of CILcare\u2019s Board. For the past six years, Aurore Marie has served as R&D project Manager and Senior Operations Manager at CILcare, responsible for directing and executing Sponsor\u2019s studies and internal R&D programs, both in Montpellier France, and Lexington, MA USA. She was notably Principal Investigator on GLP ototoxicity and general toxicity studies over the 3 last years. Within […]<\/p>","protected":false},"author":3,"featured_media":5728,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5714","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classe","entry","has-media"],"yoast_head":"\nAurore Marie promoted as Global Head, R&D Operations Management, and CILcare\u2019s Board Member - Cilcare<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cilcare.com\/jp\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aurore Marie promoted as Global Head, R&D Operations Management, and CILcare\u2019s Board Member - Cilcare\" \/>\n<meta property=\"og:description\" content=\"Montpellier, October 13th, 2021: CILcare, the world leading CRO specialized in ear disorders, is pleased of nominating Aurore Marie at the position of Global Head, R&D Operations Management. In her new role, Aurore Marie will drive the support to production operations at global level and will serve as a new member of CILcare\u2019s Board. For the past six years, Aurore Marie has served as R&D project Manager and Senior Operations Manager at CILcare, responsible for directing and executing Sponsor\u2019s studies and internal R&D programs, both in Montpellier France, and Lexington, MA USA. She was notably Principal Investigator on GLP ototoxicity and general toxicity studies over the 3 last years. Within […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cilcare.com\/jp\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/\" \/>\n<meta property=\"og:site_name\" content=\"Cilcare\" \/>\n<meta property=\"article:published_time\" content=\"2021-10-12T14:10:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-14T18:10:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2021\/10\/MG_8821-cropped-1024x653.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"653\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"CILcare\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"CILcare\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/\",\"url\":\"https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/\",\"name\":\"Aurore Marie promoted as Global Head, R&D Operations Management, and CILcare\u2019s Board Member - Cilcare\",\"isPartOf\":{\"@id\":\"https:\/\/www.cilcare.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2021\/10\/MG_8821-cropped.png\",\"datePublished\":\"2021-10-12T14:10:20+00:00\",\"dateModified\":\"2023-11-14T18:10:55+00:00\",\"author\":{\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/#primaryimage\",\"url\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2021\/10\/MG_8821-cropped.png\",\"contentUrl\":\"https:\/\/www.cilcare.com\/wp-content\/uploads\/2021\/10\/MG_8821-cropped.png\",\"width\":5152,\"height\":3287},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cilcare.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aurore Marie promoted as Global Head, R&D Operations Management, and CILcare\u2019s Board Member\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cilcare.com\/#website\",\"url\":\"https:\/\/www.cilcare.com\/\",\"name\":\"Cilcare\",\"description\":\"Making hearing a priority\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cilcare.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac\",\"name\":\"CILcare\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\/\/www.cilcare.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g\",\"caption\":\"CILcare\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aurore Marie promoted as Global Head, R&D Operations Management, and CILcare\u2019s Board Member - Cilcare","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cilcare.com\/jp\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/","og_locale":"ja_JP","og_type":"article","og_title":"Aurore Marie promoted as Global Head, R&D Operations Management, and CILcare\u2019s Board Member - Cilcare","og_description":"Montpellier, October 13th, 2021: CILcare, the world leading CRO specialized in ear disorders, is pleased of nominating Aurore Marie at the position of Global Head, R&D Operations Management. In her new role, Aurore Marie will drive the support to production operations at global level and will serve as a new member of CILcare\u2019s Board. For the past six years, Aurore Marie has served as R&D project Manager and Senior Operations Manager at CILcare, responsible for directing and executing Sponsor\u2019s studies and internal R&D programs, both in Montpellier France, and Lexington, MA USA. She was notably Principal Investigator on GLP ototoxicity and general toxicity studies over the 3 last years. Within […]","og_url":"https:\/\/www.cilcare.com\/jp\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/","og_site_name":"Cilcare","article_published_time":"2021-10-12T14:10:20+00:00","article_modified_time":"2023-11-14T18:10:55+00:00","og_image":[{"width":1024,"height":653,"url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2021\/10\/MG_8821-cropped-1024x653.png","type":"image\/png"}],"author":"CILcare","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"CILcare","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"2\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/","url":"https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/","name":"Aurore Marie promoted as Global Head, R&D Operations Management, and CILcare\u2019s Board Member - Cilcare","isPartOf":{"@id":"https:\/\/www.cilcare.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/#primaryimage"},"image":{"@id":"https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2021\/10\/MG_8821-cropped.png","datePublished":"2021-10-12T14:10:20+00:00","dateModified":"2023-11-14T18:10:55+00:00","author":{"@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac"},"breadcrumb":{"@id":"https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/#primaryimage","url":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2021\/10\/MG_8821-cropped.png","contentUrl":"https:\/\/www.cilcare.com\/wp-content\/uploads\/2021\/10\/MG_8821-cropped.png","width":5152,"height":3287},{"@type":"BreadcrumbList","@id":"https:\/\/www.cilcare.com\/2021\/10\/12\/aurore-marie-nominated-global-head-rd-operations-management\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cilcare.com\/"},{"@type":"ListItem","position":2,"name":"Aurore Marie promoted as Global Head, R&D Operations Management, and CILcare\u2019s Board Member"}]},{"@type":"WebSite","@id":"https:\/\/www.cilcare.com\/#website","url":"https:\/\/www.cilcare.com\/","name":"Cilcare","description":"Making hearing a priority","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cilcare.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Person","@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/71c4c9a5956da88e9a9de08ad23b27ac","name":"CILcare","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/www.cilcare.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/4bc8be812ab5693ac188aed8222fa384249de7201f47b7b8db392d1474d732de?s=96&d=mm&r=g","caption":"CILcare"}}]}},"_links":{"self":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/5714","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/comments?post=5714"}],"version-history":[{"count":1,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/5714\/revisions"}],"predecessor-version":[{"id":11005,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/posts\/5714\/revisions\/11005"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media\/5728"}],"wp:attachment":[{"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/media?parent=5714"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/categories?post=5714"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cilcare.com\/jp\/wp-json\/wp\/v2\/tags?post=5714"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}